Cohort study
This presentation is the property of its rightful owner.
Sponsored Links
1 / 41

Cohort Study PowerPoint PPT Presentation


  • 122 Views
  • Uploaded on
  • Presentation posted in: General

Cohort Study. Presenter : Dr Himani Moderator: Dr Subodh S Gupta. Types of Epidemiological study. Framework. Definition Study design Steps of study Identification of study population Measurement of exposure selection of study and comparison group

Download Presentation

Cohort Study

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Cohort study

Cohort Study

Presenter : Dr Himani

Moderator: Dr Subodh S Gupta


Types of epidemiological study

Types of Epidemiological study


Framework

Framework

  • Definition

  • Study design

  • Steps of study

    Identification of study population

    Measurement of exposure

    selection of study and comparison group

    Follow-up

    Analysis

    4. Advantages and disadvantages

    5. Biases

    6. Variants of cohort study

    7. Cohort study and other study designs

    8. Role of Cohort study in Epidemiology


Definition

Definition

  • The cohort study is an observational analytical epidemiological study which, after the manner of an experiment, attempts to study the relationship between a purported cause (exposure)and the subsequent risk of developing disease.

  • Synonyms: Incidence studies, prospective studies, follow-up studies, longitudinal studies


Study design

Study design


Indication of cohort study

Indication of Cohort study

  • When there is good evidence of exposure and disease.

  • When exposure is rare and incidence of disease amongst exposed group is more

  • When follow-up is easy

  • When sufficient funds are available


Types of cohort

Types of cohort

  • Open Cohort: Subjects can leave and enter the cohort at any time

  • Closed Cohort : Fixed number of persons are followed over a specified time till the end point.


Steps of cohort study

Steps of Cohort study

  • Identification of study population

  • Measurement of exposure

  • Selection of study and comparison group

  • Follow-up (for outcome measurement)

  • Analysis


Criteria for the selection of subjects in cohort

Criteria for the selection of subjects in cohort

  • Free of disease of interest

  • Equally susceptible to development of the disease at the beginning of the study

  • Equivalent information (quantity and quality) should be available on exposure and disease

  • Both the groups should be accessible and available for follow- up.


Selection of comparison group

Selection of Comparison group

  • Internal comparison

    • Single cohort enters the study

    • Later on, classified into study and comparison cohort based on exposure

  • External comparison

    • More than one cohort identified

    • e.g. Cohort of radiologist compared with ophthalmologists or smokers with non smokers

  • Comparison with general population rates

    • If no comparison group is available we can compare the rates of study cohort with general population

    • Frequency of cancer amongst asbestos workers compared with cancer in general population


Gathering data on exposure

Gathering data on exposure

  • Existing Records

  • Interviews, self administered questionnaire, mailed questionnaire

  • Examinations: medical and other special examinations

  • Measure of environment: measure of air pollution, exposure to radiation or other toxicological substances


Follow up

Follow up

Objectives of Follow up

  • uniform and complete follow-up of all cohort groups

  • complete ascertainment of outcome events

  • standardized diagnosis of outcome events.

    Methods:

  • correspondence with the subject and other informants,

  • periodic re-examination of the subjects, and

  • indirect surveillance of hospital records and death certificates.


Sample size calculation

Sample size calculation

The estimated sample size n for cohort studies is calculated as

N= [Zα √(1+1/m)p(1-p) +Zβ √ {p0(1-p0) / m} +p1(1-p1)]2

(po-p1)2

Where

m = number of control subjects per experimental subject

po= probability of events in control

p1 =probability of events in experimental subjects

p= p1+ m po

m+1


Sample size calculation1

Sample Size calculation

When mean is available

n=sample size

µ1= population mean in group1

µ2= population mean in group2

µ1- µ2 = difference the investigator wishes to detect

σ = population variance (SD)

a= conventional multiplier for alpha =0.05

b= conventional multiplier for power = 0.80


Analysis of cohort study

Analysis of Cohort study

  • Relative risk or risk ratio

  • Risk difference

  • Attributable risk

  • Population Attributable Risk

  • Rate Ratio


Cohort study

Incidence (exposed) = Exposed persons who developedds= a/(a+b)

All exposed person

Incidence (Unexposed) = Unexposed persons who develop ds= c/(c+d)

All unexposed persons

Relative Risk = _Incidence (exposed)__ = _a / (a+b)_

Incidence (unexposed) c / (c+d)

Risk difference = Incidence (exposed) – Incidence(nonexposed)

= [a/(a+b)] – c/(c+d)]


Cohort study

Attributable Risk =

Risk(exposed) – Risk(nonexposed) * 100

Risk (exposed)

= (RR-1) * 100

RR

Population Attributable Risk=

Risk(Total) – Risk(unexposed) *100

Risk (total)


Cohort study

  • Incidence (exposed) = Exposed persons who develop ds= 200/10,000 = 0.02

  • All exposed person

  • Incidence (Unexposed) = Unexposed persons who develop ds= 100/10,000 =0.01

  • All unexposed persons

  • Relative Risk = _Incidence (exposed)__ = _0.02 = 2

  • Incidence (unexposed) 0.01

  • Risk difference = Incidence (exposed) – Incidence(nonexposed)

  • = 0.02 – 0.01 = 0.01


Cohort study

  • Attributable risk: {(2-1)/2}*100 = 50%

  • Population attributable risk= {(0.015- 0.01)/0.02}*100

    = 25%


Cohort study

  • Cumulative incidence

    Number of new cases of disease occurring over a specified period of time in a population at risk

  • Incidence density

    Number of new cases of disease occurring over a specified period of time in a population at risk throughout an interval


Cohort study

Rate ratio=rate of outcome amongst exposed/ rate of outcome among unexposed

Rate ratio= [a/ PT(exposed)] / [b/PT(unexposed)]


Survival analysis

Survival Analysis

  • Statistical method for analyzing longitudinal data on occurrence of events.

  • Events can be

    Time to death

    time to onset of disease

    length of stay in hospital

    viral load measurement


Survival analysis1

Survival analysis

  • Life table approach

  • Kaplan Mier

  • Cox Regression


Clinically suspected cases

Clinically suspected cases

Event free survival


Advantages of cohort study

Advantages of cohort study

  • Direct calculation of risk ratio (relative risk)

  • Yield information on incidence of disease

  • Clear temporal relationship between exposure and disease

  • Particularly efficient for study of rare exposures

  • Can yield information on multiple outcomes of a particular exposure

  • Minimize bias

  • Strongest observational design for establishing cause and effect relationship


Disadvantages of cohort study

Disadvantages of cohort study

  • Time consuming

  • Often requires a large sample size

  • Expensive

  • Not efficient for study of rare diseases

  • Losses to follow-up may diminish validity

  • Changes over time in diagnostic methods may lead to biased results


Biases

Biases

  • Selection bias

  • Information bias/ Misclassification bias

  • Bias due to confounding

  • Post hoc bias.


Selection bias

Selection Bias

  • the group actually studied does not reflect the same distribution of factors (such as age, smoking, race, etc.) as occurs in the general population.

  • This is due to

    members refuse to participate

    records are not available

    Particular subgroup may not be representative of general population

  • Resolution: by careful selection of individuals for inclusion in the study and by making every attempt to characterize differences that may exist between respondents and non-respondents.


Selection bias in historical cohort

Selection Bias in historical cohort

True RR =2.0

20% of employee heath records were lost or discarded, except in “solvent” workers who reported illness (1%loss)

RR=2.42


Follow up bias

Follow- up Bias

  • Some members of the original cohort drop-out of the study

  • If the loss to follow-up occurs equally in the exposed and unexposed groups, and their characteristics are nearly similar, the internal validity should not be affected.

  • Resolution:

    by intensive follow up

    comparison of baseline characteristics of those who are loss to follow up and those who are not


Cohort study

Differential loss to follow up in a prospective cohort study on oral contraceptives and thromboembolism(TE)

RR= 2 (truth)

After 40% loss to follow up

RR=1


Information bias

Information Bias

  • Also known as ‘misclassification bias’

  • result from measurement errors, imprecise measurement, and misdiagnosis for whatever reason.

  • Resolution: by using well-defined precise measurements and classification criteria for which the sensitivity and specificity have been determined.


Post hoc bias

Post hoc bias

  • use of data from a cohort study to make observations that were not part of the original study intent.

  • These findings should be treated as hypotheses that are an appropriate subject for additional studies.


Bias due to confounding

Bias due to Confounding

  • When other factors that are associated with both the outcome and exposure variables do not have the same distribution in the exposed and unexposed groups.

  • Confounder should have 3 criterias:

  • it should be cause of disease

  • it is associated with risk of disease

  • it should not be an intermediate step in causal pathway between exposure and disease


Cohort study

  • During design of study

    randomisation

    restriction

    matching

  • During analysis

    stratification

    statistical modelling


Variant of cohort study

Variant of Cohort study

  • Nested Case-Control study


Nested case control study

Nested Case-control study


Cohort study and other studies in epidemiology

Cohort study and other studies in epidemiology


Role of cohort study in epidemiology

Role of cohort study in epidemiology

  • Natural history of the disease:

    For example, cohort studies of individuals who were infected with HIV revealed that a drop in the level of T lymphocytes having the CD4 marker was associated with being infected with HIV, and that a further decline in CD4 cells was associated with developing clinical symptoms and AIDS

  • Causation of the disease:

    eg. role of high blood pressure as a major cause of stroke, myocardial infarction, and chronic kidney disease.

  • Evaluating public health programmes:

    If relevant statistics are not routinely available, cohort studies can be used to assess whether the programme has an impact by calculating the incidence of a disease.


References

References

1. Gordis L, Epidemiology, Third Edition(2004), Elsevier Saunders.

2. Detels R, McEwen J, Beaglehole R, Tanaka H, Oxford Textbook of Public Health, Fourth edition(2002), Oxford University Press

3. Beaglehole R, Bonita R, Kjellstrom T, Basic Epidemiology, 2nd Edition(2006)WHO.

4. Hill, Mc Graw, Medical Epidemiology, 4th Edition(2007), Lange.

5. Bhalwar R, Vaidya R, Tilak R, Gupta R, Kunte R, Textbook of Public Health and Community Medicine. 1st Edition (2009).

6. Kasiulevičius V, Šapoka V, Filipavičiūtė R, Sample size calculation in epidemiological studies, Gerontologija 2006; 7(4): 225–31

7. Grimes DA, Schulz KF, Cohort studies: marching towards outcome, Lancet2002;359:341-45.


  • Login